Hypothalamic compensatory mechanisms in Parkinson's disease

The International Journal of Neuroscience
R Sandyk

Abstract

Parkinson's disease (PD) is associated with loss of dopaminergic neurons of the nigrostriatal bundle and to a lesser extent of the mesolimbic and hypothalamic dopaminergic systems. Frank symptoms of the disease usually emerge when at least 70-80% of striatal dopamine (DA) content have been reduced, raising the possibility that the preclinical phase of the disease might be due to compensatory changes that permit residual dopaminergic neurons to subserve functions previously carried out by the entire projection. These neurochemical compensatory mechanisms are known to occur at a striatal level of the rate limiting enzymes of catecholamine synthesis as well as alterations in the sensitivity of the dopaminergic postsynaptic receptors (Zigmond et al., 1984; Bokobza et al., 1984). Compensatory mechanisms, although generally less well recognized, also occur in the hypothalamus and involve endocrine regulation, abnormal neuropeptide release and the emergence of several autonomic and sensory symptoms manifesting prior to or during the course of the disease. Such neurochemical and clinical adaptation mechanisms of the hypothalamus may help to explain the neurobiological events underlying the preclinical phase of Parkinsonism. Moreover, p...Continue Reading

References

Aug 28, 1978·Life Sciences·C E Johanson
Feb 1, 1976·The British Journal of Psychiatry : the Journal of Mental Science·A H Robins
Nov 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·A H Rajput, B Rozdilsky
Nov 1, 1978·Neurology·B I Diamond, R L Borison
Jun 1, 1977·Journal of the American Geriatrics Society·P RosenbergB Beilin
Feb 1, 1978·Annals of Neurology·J W Langston, L S Forno
May 1, 1976·Neurology·S R SniderL J Cote
Feb 1, 1987·The International Journal of Neuroscience·R Sandyk, R P Iacono
Apr 1, 1987·The International Journal of Neuroscience·R Sandyk, R P Iacono
Jan 1, 1986·Neurology·C G GoetzC M Tanner
Jan 22, 1972·Lancet·M GrossR Godwin-Austen
Mar 3, 1973·Lancet·S ShusterD Bates
Aug 1, 1967·Journal of Neurology, Neurosurgery, and Psychiatry·J W Warburton
Aug 1, 1974·The Journal of Clinical Endocrinology and Metabolism·W B MalarkeyG W Paulson
Aug 1, 1974·The Journal of Physiology·J A Boulant
Sep 15, 1972·Life Sciences. Pt. 1: Physiology and Pharmacology·Z L Kruk
Sep 1, 1973·The Journal of Clinical Endocrinology and Metabolism·W A BrownL M Ambani
Jan 1, 1971·Archives of Neurology·O Appenzeller, J E Goss
Oct 1, 1966·Journal of Neurology, Neurosurgery, and Psychiatry·S S Gubbay, D D Barwick
May 1, 1981·The Journal of Nervous and Mental Disease·M ToruK Sugano
May 1, 1984·Neurology·F Javoy-AgidY Agid
May 1, 1982·Peptides·T L O'Donohue, D M Dorsa
Sep 1, 1983·Annals of Neurology·O LindvallG Skagerberg
Feb 1, 1984·Neurology·G P SechiR Mutani
Nov 1, 1980·Journal of Neurology, Neurosurgery, and Psychiatry·N F Lawton, J MacDermot
Oct 1, 1981·Neurology·T EislerD B Calne
Nov 1, 1982·Archives of Neurology·S Akpinar

❮ Previous
Next ❯

Citations

Nov 1, 1988·Neuroscience·R Sandyk
Sep 1, 1992·The International Journal of Neuroscience·R Sandyk, G L Willis
Jan 13, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Dagmar VerbaanJacobus J van Hilten
Jan 1, 1995·Pain·E H Chudler, W K Dong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.